Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | melatonin receptor 1A | References | |
Homo sapiens | melatonin receptor 1B | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | hypothetical protein | melatonin receptor 1B | 362 aa | 329 aa | 18.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | NADPH oxidoreductase, putative | 0.0171 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0171 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0171 | 1 | 0.5 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0171 | 1 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0171 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | Blocking the inhibitory effect of 1 nM melatonin. | ChEMBL. | 7932550 | |
Activity (functional) | 0 | Blocking the inhibitory effect of 1 nM melatonin. | ChEMBL. | 7932550 |
cAMP activity index (functional) | = 0.18 | Activity (expressed as cAMP index) measured by the melatonin-mediated inhibition of forskolin-stimulated cAMP production | ChEMBL. | 7932550 |
cAMP activity index (functional) | = 0.18 | Activity (expressed as cAMP index) measured by the melatonin-mediated inhibition of forskolin-stimulated cAMP production | ChEMBL. | 7932550 |
IC50 (binding) | = 4 | Melatonin receptor type 1A binding affinity measured using 2-[125I]-iodomelatonin on ovine pars tuberalis membrane homogenates. | ChEMBL. | 9804685 |
IC50 (binding) | > 0.00001 M | Monophasic inhibitory concentration against melatonin receptor was measured on ovine pars tuberalis membrane. | ChEMBL. | 7932550 |
IC50 (binding) | > 0.00001 M | Monophasic inhibitory concentration against melatonin receptor was measured on ovine pars tuberalis membrane. | ChEMBL. | 7932550 |
Kd (binding) | = 0.0000026 | Binding affinity to melatonin receptor measured on ovine pars tuberalis membrane | ChEMBL. | 7932550 |
Kd (binding) | = 0.0000026 | Binding affinity to melatonin receptor measured on ovine pars tuberalis membrane | ChEMBL. | 7932550 |
Kd (binding) | = 2.33 l M-1 | Binding affinity against Melatonin receptor using ovine pars tuberalis membranes of the pituitary. | ChEMBL. | 1315395 |
Kd (binding) | = 2.33 l M-1 | Binding affinity against Melatonin receptor using ovine pars tuberalis membranes of the pituitary. | ChEMBL. | 1315395 |
Log IC50 (binding) | = 4 | Melatonin receptor type 1A binding affinity measured using 2-[125I]-iodomelatonin on ovine pars tuberalis membrane homogenates. | ChEMBL. | 9804685 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
3 literature references were collected for this gene.